Verdemed
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Verdemed - overview
Location
Toronto, ON, Canada
Primary Industry
Pharmaceuticals
About
Based in Ontario, Canada, Verdemed is a company that develops cannabis-based pharmaceuticals. They develop the two cannabinoids THC (tetrahydrocannabinol) and CBD (cannabidiol) to be used in medicine to substitute endogenous cannabinoids and connecting with the receptors CB1 and CB2. It is used as a safe medicine in various conditions such as an antiemetic in the treatment of chemotherapy-induced nausea and vomiting, child epilepsy, treatment for chronic pain in adults and as an adjunctive therapy for cancer-related pain, and muscle spasticity treatment.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.verdemed.com
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Verdemed - employee data
Verdemed - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman Of The Board | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.